Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II

被引:13
作者
Sengupta, T
Mukherjee, M
Das, R
Das, A
Majumder, HK
机构
[1] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata 700032, W Bengal, India
[2] Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA
关键词
D O I
10.1093/nar/gki527
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA topoisomerase II is a multidomain homodimeric enzyme that changes DNA topology by coupling ATP hydrolysis to the transport of one DNA helix through a transient double-stranded break in another. To investigate the biochemical properties of the individual domains of Leishmania donovani topoisomerase II, four truncation mutants were generated. Deletion of 178 aminoacids from the C-terminus (core and Ld Delta C1058) had no apparent effect on the DNA-binding or cleavage activities of the enzymes. However, when 429 aminoacids from the N-terminus and 451 aminoacids from the C-terminus were removed (Ld Delta N Delta C), the enzyme was no longer active. Moreover, the removal of 429 aminoacids from the N-terminus (Ld Delta N Delta C, core and Ld Delta N429) render the mutant proteins incapable of performing ATP hydrolysis. The mutant proteins show cleavage activities at wide range of KCl concentrations (25-350 mM). In addition, the mutant proteins, excepting Ld Delta N Delta C, can also act on kDNA and linearize the minicircles. Surprisingly, the mutant proteins fail to show the formation of the enhanced cleavable complex in the presence of etoposide. Our findings suggest that the conformation required for interaction with the drug is absent in the mutant proteins. Here, we have also identified Tyr(775) through direct sequencing of the DNA linked peptide as the catalytic residue implicated in DNA-breakage and rejoining. Taken together, our results demonstrate that topoisomerase II are functionally and mechanistically conserved enzymes and the variations in activity seem to reflect functional optimization for its physiological role during parasite genome replication.
引用
收藏
页码:2364 / 2373
页数:10
相关论文
共 42 条
[1]   STRAND SPECIFICITY OF THE TOPOISOMERASE-II MEDIATED DOUBLE-STRANDED DNA CLEAVAGE REACTION [J].
ANDERSEN, AH ;
CHRISTIANSEN, K ;
ZECHIEDRICH, EL ;
JENSEN, PS ;
OSHEROFF, N ;
WESTERGAARD, O .
BIOCHEMISTRY, 1989, 28 (15) :6237-6244
[2]   Cobalt enhances DNA cleavage mediated by human topoisomerase IIα in vitro and in cultured cells [J].
Baldwin, EL ;
Byl, JAW ;
Osheroff, N .
BIOCHEMISTRY, 2004, 43 (03) :728-735
[3]   An unusual type IB topoisomerase from African trypanosomes [J].
Bodley, AL ;
Chakraborty, AK ;
Xie, SJ ;
Burri, C ;
Shapiro, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7539-7544
[4]   Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model [J].
Brandt, TA ;
Jacobs, BL .
JOURNAL OF VIROLOGY, 2001, 75 (02) :850-856
[5]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[6]   The ATP-operated clamp of human DNA topoisomerase IIα:: Hyperstimulation of ATPase by "piggy-back" binding [J].
Campbell, S ;
Maxwell, A .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (02) :171-188
[7]   Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congeners [J].
Capranico, G ;
Guano, F ;
Moro, S ;
Zagotto, G ;
Sissi, C ;
Gatto, B ;
Zunino, F ;
Menta, E ;
Palumbo, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12732-12739
[8]  
CAREY J, 1991, METHOD ENZYMOL, V208, P103
[9]   Analysis of a core domain in Drosophila DNA topoisomerase II -: Targeting of an antitumor agent ICRF-159 [J].
Chang, S ;
Hu, T ;
Hsieh, TS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19822-19828
[10]   Phosphorylation of serine 1106 in the catalytic domain of topoisomerase IIα regulates enzymatic activity and drug sensitivity [J].
Chikamori, K ;
Grabowski, DR ;
Kinter, M ;
Willard, BB ;
Yadav, S ;
Aebersold, RH ;
Bukowski, RM ;
Hickson, ID ;
Andersen, AH ;
Ganapathi, R ;
Ganapathi, MK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :12696-12702